Baker Botts advised Waste Management on the deal. Waste Management, Inc. (NYSE: WM) (“WM” or the “Company”) announced the pricing of its public offering of $1,000,000,000...
Waste Management’s $1 Billion Senior Notes Offering
CenterPoint Energy Houston Electric’s $800 Million General Mortgage Bond Offering
Baker Botts advised CenterPoint Energy Houston Electric on the deal. CenterPoint Energy Houston Electric, LLC (“CEHE”), an indirect, wholly-owned subsidiary of CenterPoint Energy, Inc. (NYSE: CNP)...
Calumet Specialty Products Partners’ $325 Million Notes Offering
Baker Botts advised initial purchasers on the deal. Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) (“Calumet”) and its wholly owned subsidiary, Calumet Finance Corp., announced the...
Cleco Power’s $325 Million Private Offering of Senior Notes
Baker Botts advised Cleco Power LLC on the deal while Hunton Andrews Kurth represented World Markets Corp. and SMBC Nikko Securities America, Inc., as initial purchasers....
Mdf commerce’s Acquisition of Periscope Intermediate Corp.
Foley & Lardner and McCarthy Tétrault LLP advised mdf commerce on the deal while Jackson Walker represented Periscope Holdings, Inc. Mdf commerce, a leader in SaaS...
Westlake Chemical Corporation’s $1.7 Billion Senior Notes Offering
Baker Botts advised Westlake Chemical Corporation on the deal, while Davis Polk advised the representatives of the underwriters. Westlake Chemical Corporation (NYSE: WLK) priced its public offering...
Tallgrass Energy’s $500 Million Notes Offering
Baker Botts advised Tallgrass Energy on the deal. Tallgrass Energy Partners, LP (“TEP”) announced that it, along with Tallgrass Energy Finance Corp., a wholly-owned subsidiary of...
Quantum Loophole’s Joint Venture with TPG Real Estate Partners
Jackson Walker advised Quantum Loophole, Inc. on the deal. Quantum Loophole, Inc. announced a strategic joint venture with TPG Real Estate Partners (TREP) to purchase an approximately...
Kamada’s Acquisition of Blood and Plasma Research Assets
Jackson Walker advised Kamada Ltd. on the deal. Kamada Ltd. announced the acquisition of the assets of Blood and Plasma Research, Inc. (B&PR), an FDA-licensed plasma...